EXTENDED ANTICOAGULANT THERAPYIN PATIENTS, WHO SURVIVED PULMONARY EMBOLISM
The review article discusses the options to extend anticoagulant therapy after completing the main anticoagulant therapy course in patients, who survived pulmonary embolism. It presents the results of randomized RE-MEDY and RE-SONATE studies of dabigatran, EINSTEIN-Extension study of rivaroxaban and...
Saved in:
Main Authors: | Natalia M. Vorobieva (Author), Elizaveta P. Panchenko (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic
by: S. Y. Martsevich, et al.
Published: (2021) -
CURRENT VIEW ON ANTICOAGULANT AND THROMBOLYTIC TREATMENT OF ACUTE PULMONARY EMBOLISM
by: G. A. Ignatenko, et al.
Published: (2019) -
Survival of Children With Pulmonary Embolism Supported by Extracorporeal Membrane Oxygenation
by: John S. Kim, et al.
Published: (2022) -
Pulmonary embolism in cancer patients. Effectiveness of vitamin K antagonists and direct oral anticoagulants in long-term therapy
by: Paulina M. Nadziakiewicz, et al.
Published: (2024) -
CLINICAL ANALYSIS OF A PATIENT WITH ANTIPHOSPHOLIPID SYNDROME AND SUB-MASSIVE PULMONARY EMBOLISM
by: E. N. Krivosheeva, et al.
Published: (2018)